The ventral tegmental area (VTA) is a key site for opioid actions, and emerging evidence suggests that pain states and opioid experience both induce transcriptional, molecular, and circuit adaptations ...
Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
As far as research subjects go, it's not always easy to find common ground with a single-celled bacterium. Yet the more Paul Wiggins studies his model bacteria, Acinetobacter baylyi, the more he sees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results